AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8580691 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (after treatment)
Number of subjects: 115
Study 31192359 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised machine learning approach using PBP sequences and MIC values to predict antimicrobial susceptibility to beta-lactam antibiotics.
Number of subjects: 0
Study 31192359 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of fragments from pbp2x (750 bp) and pbp2b (750 bp) for prediction.
Number of subjects: 0
Study 31192359 — intervention group
Group type: EXPERIMENTAL
Intervention: Association analysis between resistance phenotypes and serotypes/sequence types of S. pneumoniae.
Number of subjects: 0
Study 28251282 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 alternate-day treatment (twice daily on alternate days from days 1 through 42 of a 42-day cycle)
Number of subjects: 190
Study 28251282 — intervention group
Group type: COMPARATOR
Intervention: S-1 daily treatment (twice daily on days 1 through 28 of a 42-day cycle)
Number of subjects: 190
Study 28251282 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 alternate-day treatment
Number of subjects: 190
Study 28251282 — intervention group
Group type: COMPARATOR
Intervention: S-1 daily treatment
Number of subjects: 190
Study 25381486 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate
Number of subjects: 351
Study 25381486 — intervention group
Group type: COMPARATOR
Intervention: Povidone iodine
Number of subjects: 351
Study 24340926 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis patients with normal BMI
Number of subjects: 41
Study 24340926 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis patients with obesity
Number of subjects: 41
Study 24340926 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 41
Study 20943824 — intervention group
Group type: COMPARATOR
Intervention: Self-administered questionnaire (SAQ)
Number of subjects: 1495
Study 20943824 — intervention group
Group type: COMPARATOR
Intervention: Audio‐SAQ
Number of subjects: 1495
Study 20943824 — intervention group
Group type: COMPARATOR
Intervention: Informal confidential voting interview (ICVI)
Number of subjects: 1495
Study 20943824 — intervention group
Group type: COMPARATOR
Intervention: Audio computer‐assisted survey instrument (ACASI)
Number of subjects: 1495
Study 18710817 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection in trapezius muscle
Number of subjects: 10
Study 18710817 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline injection in trapezius muscle (control)
Number of subjects: 10
Study 16752180 — intervention group
Group type: EXPERIMENTAL
Intervention: [U‐(13)C]glucose and [3‐(14)C]lactate infusion during a 24‐h fast
Number of subjects: 13
Study 16752180 — intervention group
Group type: COMPARATOR
Intervention: Control group (age‐ and BMI‐matched)
Number of subjects: 13
Study 16752180 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic subjects
Number of subjects: 13
Study 16752180 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin secretion
Number of subjects: 13
Study 15177970 — intervention group
Group type: EXPERIMENTAL
Intervention: One 600‐mg tablet (group 1A, 13 patients sampled < 2 hours after administration)
Number of subjects: 29
Study 15177970 — intervention group
Group type: EXPERIMENTAL
Intervention: One 600‐mg tablet (group 1B, 9 patients sampled > 2 hours after administration)
Number of subjects: 29
Study 15177970 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of 600 mg given 12 hours apart (group 2, 7 patients)
Number of subjects: 29
Study 11387491 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal transcranial magnetic stimulation (TMS) over motor and premotor cortices
Number of subjects: 41
Study 9408786 — intervention group
Group type: EXPERIMENTAL
Intervention: CATCH intervention programs (school food service, physical education, classroom curricula, home programs)
Number of subjects: 0
Study 7678976 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin/5-Fluorouracil
Number of subjects: 16
Study 7678976 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatinum
Number of subjects: 16
Study 3112262 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous midazolam (0.1 mg/kg)
Number of subjects: 50
Study 3112262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 28497206 — intervention group
Group type: EXPERIMENTAL
Intervention: Online group (taught by videos)
Number of subjects: 54
Study 28497206 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom group (traditional lecture with hands-on training)
Number of subjects: 54
Study 28497206 — intervention group
Group type: COMPARATOR
Intervention: Control group (not taught at all)
Number of subjects: 54
Study 27391406 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (counselling sessions led by a social worker)
Number of subjects: 74
Study 27391406 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 74
Study 24225450 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg daidzein (DAI40)
Number of subjects: 210
Study 24225450 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg daidzein (DAI80)
Number of subjects: 210
Study 24225450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 22101910 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg/d)
Number of subjects: 55
Study 22101910 — intervention group
Group type: COMPARATOR
Intervention: Diet alone (Control)
Number of subjects: 55
Study 20937093 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized heparin (25,000 U) administered 4 or 6 hourly depending on patient height
Number of subjects: 50
Study 20937093 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline) administered 4 or 6 hourly depending on patient height
Number of subjects: 50
Study 18763689 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonicare Elite (Elite)
Number of subjects: 180
Study 18763689 — intervention group
Group type: COMPARATOR
Intervention: Oral‐B P40 manual toothbrush (MTB)
Number of subjects: 180
Study 18763689 — intervention group
Group type: EXPERIMENTAL
Intervention: Both toothbrushes
Number of subjects: 180
Study 15983958 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet (30 to 180 mg once daily)
Number of subjects: 54
Study 15983958 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 14763035 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (ARB)
Number of subjects: 24
Study 14763035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 10582841 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Performance Test (CPT)
Number of subjects: 341
Study 8609293 — intervention group
Group type: EXPERIMENTAL
Intervention: Target fixed at 753 Hz, distractor frequencies: 353, 553, 653, 703, 803, 853, 953, 1153 Hz; interaural delays varied from -90 to +90 microseconds in 20-microsecond steps; 100 trials per block.
Number of subjects: 8
Study 8609293 — intervention group
Group type: EXPERIMENTAL
Intervention: Distractor fixed at 753 Hz, target frequencies: 353, 553, 653, 703, 803, 953, 1153 Hz; interaural delays varied from -90 to +90 microseconds in 20-microsecond steps; 100 trials per block.
Number of subjects: 8
Study 1911483 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable subcuticular sutures
Number of subjects: 304
Study 1911483 — intervention group
Group type: COMPARATOR
Intervention: Non-absorbable interrupted sutures
Number of subjects: 304
Study 31478731 — intervention group
Group type: EXPERIMENTAL
Intervention: S. aureus positive isolates
Number of subjects: 311
Study 31478731 — intervention group
Group type: EXPERIMENTAL
Intervention: Methicillin-resistant strains
Number of subjects: 311
Study 31478731 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-drug resistance
Number of subjects: 311
Study 31478731 — intervention group
Group type: COMPARATOR
Intervention: Risk factors evaluation
Number of subjects: 311
Study 30305263 — intervention group
Group type: EXPERIMENTAL
Intervention: Cool Runnings app-based intervention
Number of subjects: 498
Study 30305263 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 498
Study 26115954 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for depression, 8 weeks
Number of subjects: 53
Study 26115954 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 53
Study 24239594 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine 3mg
Number of subjects: 41
Study 24239594 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine 6mg
Number of subjects: 41
Study 24239594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 22916864 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium-polyethylene (TI) implant
Number of subjects: 43
Study 22916864 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrocarbon (PY) implant
Number of subjects: 43
Study 22916864 — intervention group
Group type: COMPARATOR
Intervention: Silicone (SI) spacer
Number of subjects: 43
Study 20581660 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (HD-DXM) at single daily doses of 40 mg for 4 consecutive days
Number of subjects: 36
Study 20581660 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 36
Study 17295794 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (daily for the first 6 months of life)
Number of subjects: 231
Study 17295794 — intervention group
Group type: COMPARATOR
Intervention: Placebo (daily for the first 6 months of life)
Number of subjects: 231
Study 17295794 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Probiotic and Placebo groups (for those who developed atopic dermatitis)
Number of subjects: 231
Study 17295794 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (specifically)
Number of subjects: 231
Study 15919837 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA)
Number of subjects: 56
Study 15919837 — intervention group
Group type: EXPERIMENTAL
Intervention: BodPod (Siri)
Number of subjects: 56
Study 15919837 — intervention group
Group type: EXPERIMENTAL
Intervention: BodPod (Brozek)
Number of subjects: 56
Study 15919837 — intervention group
Group type: COMPARATOR
Intervention: DXA
Number of subjects: 56
Study 15919837 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation coefficients for detecting changes in body composition
Number of subjects: 56
Study 12602413 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV plus LTOT
Number of subjects: 0
Study 12602413 — intervention group
Group type: COMPARATOR
Intervention: LTOT
Number of subjects: 0
Study 10714795 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid same day multiplex PCR assay for detection of the staphylococcal mecA (mean delay of response: 6 h)
Number of subjects: 145
Study 10714795 — intervention group
Group type: COMPARATOR
Intervention: Traditional overnight techniques (21 h)
Number of subjects: 145
Study 10714795 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid same day multiplex PCR assay for detection of the staphylococcal mecA
Number of subjects: 145
Study 10714795 — intervention group
Group type: COMPARATOR
Intervention: Traditional overnight techniques
Number of subjects: 145
Study 8746877 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-IUD 5 micrograms/24 h
Number of subjects: 51
Study 8746877 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-IUD 10 micrograms/24 h
Number of subjects: 51
Study 2036815 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol therapy
Number of subjects: 0
Study 2036815 — intervention group
Group type: COMPARATOR
Intervention: Humidity therapy
Number of subjects: 0
Study 7094200 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (with or without radiotherapy) plus MER/BCG (RCM)
Number of subjects: 73
Study 7094200 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy either alone or in combination with radiotherapy (RC)
Number of subjects: 73
Study 28772092 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialty palliative care in addition to standard oncology care
Number of subjects: 30
Study 28772092 — intervention group
Group type: COMPARATOR
Intervention: Standard oncology care alone
Number of subjects: 30
Study 26947543 — intervention group
Group type: COMPARATOR
Intervention: Intravenous TXA (IVTXA)
Number of subjects: 70
Study 26947543 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TXA (TTXA)
Number of subjects: 70
Study 25552287 — intervention group
Group type: EXPERIMENTAL
Intervention: RTF plus PRF
Number of subjects: 36
Study 25552287 — intervention group
Group type: EXPERIMENTAL
Intervention: PRF
Number of subjects: 36
Study 25552287 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 23820670 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support
Number of subjects: 106
Study 23820670 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 106
Study 23820670 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 106
Study 20872194 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium and salmeterol (experimental group, n = 10)
Number of subjects: 20
Study 20872194 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 20
Study 18215253 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative melatonin application
Number of subjects: 40
Study 18215253 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 40
Study 16617223 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (aerobic exercise and muscle strengthening, 24 sessions over 2 months)
Number of subjects: 30
Study 16617223 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 30
Study 16617223 — intervention group
Group type: COMPARATOR
Intervention: Control group (2-month control period)
Number of subjects: 30
Study 14711141 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT using ALA plus blue light
Number of subjects: 36
Study 14711141 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT using ALA plus laser light
Number of subjects: 36
Study 14711141 — intervention group
Group type: COMPARATOR
Intervention: Topical 5‐FU
Number of subjects: 36
Study 14711141 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 36
Study 14711141 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT treatments (both types)
Number of subjects: 36
Study 11281438 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin 500 mg tid + Omeprazole 20 mg bd
Number of subjects: 148
Study 11281438 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin 750 mg tds + Omeprazole 20 mg bd
Number of subjects: 148
Study 11281438 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg tid + Omeprazole 20 mg bd
Number of subjects: 148
Study 9426077 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol inhalation (267 mg and 400 mg)
Number of subjects: 12
Study 9426077 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol inhalation
Number of subjects: 12
Study 8229541 — intervention group
Group type: COMPARATOR
Intervention: 0% MCT oil
Number of subjects: 64
Study 8229541 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% MCT oil
Number of subjects: 64
Study 8229541 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% MCT oil
Number of subjects: 64
Study 8229541 — intervention group
Group type: EXPERIMENTAL
Intervention: 34% MCT oil
Number of subjects: 64
Study 3941767 — intervention group
Group type: EXPERIMENTAL
Intervention: Primidone (50 to 1,000 mg/d)
Number of subjects: 0
Study 3941767 — intervention group
Group type: EXPERIMENTAL
Intervention: Primidone (250 mg single oral dose)
Number of subjects: 0
Study 3941767 — intervention group
Group type: EXPERIMENTAL
Intervention: Primidone
Number of subjects: 0
Study 3941767 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0
Study 3941767 — intervention group
Group type: COMPARATOR
Intervention: Phenobarbital (substituted for primidone)
Number of subjects: 0
Study 29280940 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 72
Study 29280940 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 72
Study 29280940 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab
Number of subjects: 72
Study 26816389 — intervention group
Group type: EXPERIMENTAL
Intervention: Combo (tracksuit pants with integrated heating elements and 5-min dryland-based exercise routine)
Number of subjects: 10
Study 26816389 — intervention group
Group type: COMPARATOR
Intervention: Control (conventional tracksuit and seated)
Number of subjects: 10
Study 26816389 — intervention group
Group type: EXPERIMENTAL
Intervention: Combo
Number of subjects: 10
Study 26816389 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study 23812661 — intervention group
Group type: EXPERIMENTAL
Intervention: LEAP
Number of subjects: 198
Study 23812661 — intervention group
Group type: EXPERIMENTAL
Intervention: TEACCH
Number of subjects: 198
Study 23812661 — intervention group
Group type: COMPARATOR
Intervention: Control (non-model-specific practices)
Number of subjects: 198
Study 23887656 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren add-on therapy
Number of subjects: 36
Study 23887656 — intervention group
Group type: COMPARATOR
Intervention: Benazepril add-on therapy
Number of subjects: 36
Study 19878195 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol
Number of subjects: 55
Study 19878195 — intervention group
Group type: COMPARATOR
Intervention: Hypertonic saline (4.5%)
Number of subjects: 55
Study 17551539 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (2 mg via polacrilex gums)
Number of subjects: 24
Study 17551539 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 24
Study 17283933 — intervention group
Group type: EXPERIMENTAL
Intervention: Convex vertices
Number of subjects: 0
Study 17283933 — intervention group
Group type: EXPERIMENTAL
Intervention: Concave vertices
Number of subjects: 0
Study 17283933 — intervention group
Group type: COMPARATOR
Intervention: Silhouettes
Number of subjects: 0
Study 12543749 — intervention group
Group type: EXPERIMENTAL
Intervention: Optic disc area measurement
Number of subjects: 70
Study 12543749 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroretinal rim area measurement
Number of subjects: 70
Study 12543749 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal cup/disc diameter ratio
Number of subjects: 70
Study 12543749 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha zone of parapapillary atrophy
Number of subjects: 70
Study 12543749 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta zone of parapapillary atrophy
Number of subjects: 70
Study 12543749 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinal arterioles and venules visibility
Number of subjects: 70
Study 12543749 — intervention group
Group type: COMPARATOR
Intervention: Comparison with white people
Number of subjects: 70
Study 9930157 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pass resolution perimetry
Number of subjects: 113
Study 9930157 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional perimetry
Number of subjects: 113
Study 9930157 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 113
Study 9930157 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 113
Study 8881668 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose regimen based on minimal phototoxic dose (MPD)
Number of subjects: 33
Study 8881668 — intervention group
Group type: COMPARATOR
Intervention: Lower dose regimen based on skin type
Number of subjects: 33
Study 8881668 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 33
Study 1909584 — intervention group
Group type: EXPERIMENTAL
Intervention: misoprostol 400 micrograms nocte
Number of subjects: 61
Study 1909584 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine 150 mg nocte
Number of subjects: 61
Study 1909584 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 61
Study 4084931 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance cardiography during maximum exercise tests
Number of subjects: 20
Study 4084931 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance cardiography
Number of subjects: 20
Study 30683150 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component sensory intervention including assessment and correction of hearing or vision impairments (or both), home-based (maximum 10 visits over 18 weeks), therapist-delivered sensory support
Number of subjects: 354
Study 30683150 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 354
Study 28876283 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based HIV prevention intervention
Number of subjects: 199
Study 28876283 — intervention group
Group type: COMPARATOR
Intervention: Participants with homelessness
Number of subjects: 199
Study 28876283 — intervention group
Group type: COMPARATOR
Intervention: Participants with clinically significant depressive symptoms
Number of subjects: 199
Study 28876283 — intervention group
Group type: COMPARATOR
Intervention: Participants who used methamphetamine or crack
Number of subjects: 199
Study 28876283 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who engaged in condomless insertive anal intercourse
Number of subjects: 199
Study 27088635 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavanol-rich chocolate
Number of subjects: 32
Study 27088635 — intervention group
Group type: COMPARATOR
Intervention: Flavanol-poor chocolate
Number of subjects: 32
Study 25295737 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab + taxane-based chemotherapy
Number of subjects: 365
Study 25295737 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety analysis of bevacizumab
Number of subjects: 365
Study 22394693 — intervention group
Group type: EXPERIMENTAL
Intervention: Komm mit in das gesunde Boot ‐ Grundschule program
Number of subjects: 427
Study 22394693 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 427
Study 20880343 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro mix 50/50 (LM50/50)
Number of subjects: 484